<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="308224">
  <stage>Registered</stage>
  <submitdate>15/07/2009</submitdate>
  <approvaldate>16/07/2009</approvaldate>
  <actrnumber>ACTRN12609000592246</actrnumber>
  <trial_identification>
    <studytitle>The Epi-No trial: Effect of intravaginal balloon device on levator trauma in mothers following childbirth</studytitle>
    <scientifictitle>The Epi-No Study: Effect of antenatal intravaginal balloon device on levator trauma in mothers following childbirth</scientifictitle>
    <utrn />
    <trialacronym>EpiNo</trialacronym>
  </trial_identification>
  <conditions>
    <healthcondition>Pelvic floor trauma in childbirth</healthcondition>
    <conditioncode>
      <conditioncode1>Reproductive Health and Childbirth</conditioncode1>
      <conditioncode2>Childbirth and postnatal care</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Use of intravaginal balloon device to distend pelvic floor muscle and reduce likelihood of traumas at childbirth, from 37 weeks' gestation to delivery. The patient inserts the device vaginally and inflates it intermittently, several times a day, to dilate the birth canal.</interventions>
    <comparator>Normal antenatal care</comparator>
    <control>Active</control>
    <interventioncode>Prevention</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Levator trauma as assessed by translabial ultrasound</outcome>
      <timepoint>3 months postpartum</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>&gt;20% increase in hiatal dimensions at rest as assessed by translabial ultrasound</outcome>
      <timepoint>3 months, 2 years postpartum</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>&gt;20% increase in hiatal dimensions on Valsalva as assessed by translabial ultrasound</outcome>
      <timepoint>3 months, 2 years postpartum</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>First pregnancy progressing beyond 20 weeks, singleton, cephalic, no contraindications to normal vaginal delivery.</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Females</inclusivegender>
    <healthyvolunteer>Yes</healthyvolunteer>
    <exclusivecriteria>Complications requiring planned Caesarean Section, multiple pregnancy, malpresentation, previous pregnancies beyond 20 weeks' gestation</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Prevention</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Participants identified through Antenatal Clinics at Nepean Hospital and Royal Prince Alfred (RPA) Hospital. Allocation at time of recruitment through phone call to third party who holds a computer-generated randomisation list concealed from researchers.</concealment>
    <sequence>Computer-generated list.</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Safety/efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>1/07/2007</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>600</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Recruiting</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>University</primarysponsortype>
    <primarysponsorname>University of Sydney</primarysponsorname>
    <primarysponsoraddress>Nepean Hospital
Derby St
Penrith 2750 NSW</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Charities/Societies/Foundations</fundingtype>
      <fundingname>Nepean medical Research Foundation</fundingname>
      <fundingaddress>PO Box 82
Emu Plains 
NSW 2750</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>The EpiNo trial is trialing the use of a commercially available intravaginal balloon device in order to determine whether this device reduces the risk of major pelvic floor trauma at vaginal delivery.</summary>
    <trialwebsite>n/a</trialwebsite>
    <publication>n/a</publication>
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Sydney West Area Health Service Human Research Ethics Committee</ethicname>
      <ethicaddress>Nepean Hospital
Derby St
Penrith 2750 NSW</ethicaddress>
      <ethicapprovaldate>30/04/2007</ethicapprovaldate>
      <hrec>1/07/0022</hrec>
      <ethicsubmitdate>25/04/2007</ethicsubmitdate>
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Prof. Hans Peter Dietz</name>
      <address>Nepean Hospital
Level 5 Spurrett Bldg.
Derby St
Penrith NSW 2750</address>
      <phone>+61 2 4734 1474</phone>
      <fax />
      <email>hpdietz@med.usyd.edu.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Prof. Hans Peter Dietz</name>
      <address>Nepean Hospital
Level 5 Spurrett Bldg.
Derby St
Penrith NSW 2750</address>
      <phone>+61 2 4734 1474</phone>
      <fax />
      <email>hpdietz@med.usyd.edu.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Prof. Hans Peter Dietz</name>
      <address>Nepean Hospital
Level 5 Spurrett Bldg.
Derby St
Penrith NSW 2750</address>
      <phone>+61 2 4734 1474</phone>
      <fax />
      <email>hpdietz@med.usyd.edu.au</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>